Contact

Dr. Torsten Knieß

Department Head
Production of Radio­pharma­ceuticals
t.kniessAthzdr.de
Phone: +49 351 260 2760

Marita Kersten

Secretariat / Administration
Institute of Radio­pharma­ceutical Cancer Research
m.kerstenAthzdr.de
Phone: +49 351 260 3223

Eye catcher

Department of Radiopharmaceutical Production

The main focus of the department is the production of radiopharmaceuticals for diagnosis of oncologic and neurologic diseases as well as for cognitive disorders by means of PET. The preferred radioisotopes used are [18F]fluorine (T1/2= 109.8 min) and [11C]carbon (T1/2 = 20.4 min).

Furthermore, 11C- and 18F-radioisotopes for radiochemistry and radiolabeled compounds for pre-clinical research are provided.

The production of PET radiopharmaceuticals is characterized by:

As all other drugs for human application the production of PET radiopharmaceuticals has to be performed according the guidelines of Good Manufacturing Practice (GMP) in compliance with national regulations and principles (Arzneimittelgesetz AMG, Arzneimittelwirkstoffherstellungs-verordnung AMWHV). Therefore, HZDR is holding a license for manufacturing of drugs (Allgemeine Herstellungserlaubnis nach §13 AMG) since 1997.


Contact

Dr. Torsten Knieß

Department Head
Production of Radio­pharma­ceuticals
t.kniessAthzdr.de
Phone: +49 351 260 2760

Marita Kersten

Secretariat / Administration
Institute of Radio­pharma­ceutical Cancer Research
m.kerstenAthzdr.de
Phone: +49 351 260 3223